Records View

Comparison of pancreatic fistula according to clip on staple line during laparoscopic distal pancreatectomy for pancreatic tumor: A randomized controlled prospective study

Status Approved

  • First Submitted Date

    2021/03/12

  • Registered Date

    2021/04/09

  • Last Updated Date

    2022/12/19

CRIS Required

WHO ICTRP (International Clinical Trial Registry Platform) Required

  • 1. Background

    Background - CRIS Registration Number, Unique Protocol ID, Public/Brief Title, Scientific Title, Acronym, MFDS Regulated Study, IND/IDE Protocol, Registered at Other Registry, Name of Registry/Registration Number
    CRIS
    Registration Number
    KCT0006074
    Unique Protocol ID 2021-0138
    Public/Brief Title Comparison of pancreatic fistula according to clip on staple line during laparoscopic distal pancreatectomy for pancreatic tumor: A randomized controlled prospective study
    Scientific Title Comparison of pancreatic fistula according to clip on staple line during laparoscopic distal pancreatectomy for pancreatic tumor: A randomized controlled prospective study
    Acronym
    MFDS Regulated Study No
    IND/IDE Protocol No
    Registered at Other Registry No
    Healthcare Benefit Approval Status Submitted approval
  • 2. Institutional Review Board / Ethics Committee

    Institutional Review Board Information
    Board Approval Status Submitted approval
    Board Approval Number 2021-0138
    Approval Date 2021-01-29
    Institutional Review Board Name Asan Medical Center Institutional Review Board
    Institutional Review Board Address 88, Olympic-ro 43-gil, Songpa-gu, Seoul
    Institutional Review Board Telephone 02-3010-7166
    Data Monitoring Committee No
  • 3. Contact Details

    Contact Details Information - Contact Person for Principal Investigator / Scientific Queries, Contact Person for Public Queries, Contact Person for Updating Information의 Name, Title, Email, Telephone, Cellular Phone, Affiliation, Address
    Contact Person for Principal Investigator / Scientific Queries
    Name song cheol Kim
    Title M.D
    Telephone +82-2-3010-3936
    Affiliation Asan Medical Center
    Address 88, Olympic-ro 43-gil, Songpa-gu, Seoul
    Contact Person for Public Queries
    Name song cheol Kim
    Title M.D
    Telephone +82-2-3010-3936
    Affiliation Asan Medical Center
    Address 88, Olympic-ro 43-gil, Songpa-gu, Seoul
    Contact Person for Updating Information
    Name seo hyun Kim
    Title CRC
    Telephone +82-2-3010-8667
    Affiliation Asan Medical Center
    Address 88, Olympic-ro 43-gil, Songpa-gu, Seoul
  • 4. Status

    Status Information - Study Site, Overall Recruitment Status, Date of First Enrollment, Status of First Enrollment, Target Number of Participant, Primary Completion Date, Recruitment Status by Participating Study Site, Name of Study Site, Recruitment Status, Date of First Enrollment, Status of First Enrollemnt
    Study Site Multi-center Number of center : 3
    Overall Recruitment Status Recruiting
    Date of First Enrollment 2021-06-24 Actual
    Target Number of Participant 190
    Primary Completion Date 2024-12-31 , Anticipated
    Study Completion Date 2024-12-31 , Anticipated
    Recruitment Status by Participating Study Site 1
    Name of Study Asan Medical Center
    Recruitment Status Recruiting
    Date of First Enrollment 2021-06-24 ,
    Recruitment Status by Participating Study Site 2
    Name of Study Samsung Medical Center
    Recruitment Status Recruiting
    Date of First Enrollment 2022-05-17 ,
    Recruitment Status by Participating Study Site 3
    Name of Study Kangbuk Samsung Medical Center
    Recruitment Status Recruiting
    Date of First Enrollment 2022-11-07 ,
  • 5. Source of Monetary / Material Support

    Source of Monetary / Material Support Information - Organization Name, Organization Type, Project ID
    1. Source of Monetary/Material Support
    Organization Name Asan Medical Center
    Organization Type Medical Institute
    Project ID 2021-0138
  • 6. Sponsor Organization

    Sponsor Organization Information - Organization Name, Organization Type
    1. Sponsor Organization
    Organization Name Asan Medical Center
    Organization Type Medical Institute
  • 7. Study Summary

    Study Summary Information
    Lay Summary
    1. Aim 
    This study is aimed to compare postoperative pancreatic fistula between reinforcement and non-reinforcement after laparoscopic distal pancreatectomy in patients with pancreatic neoplasm and conclusion of this study may give answer for clinical guideline for laparoscopic distal pancreatectomy. 
    
    2. Background 
    Previous studies showed comparable safety of laparoscopic surgery compared with open srugery, and the patients with laparoscopy experienced early recovery compared with open surgery.
    Although previous study showed the patients with reinforcement after lap DP showed lower posoperative pancreatic fistula, the role of reinforcement after laparoscopic distal pancreatectomy is unclear in currence guideline for minimally invasive pancreatice surgery. 
    Therefore, we plan to compare postoperative pancreatic fistula according to the reinforcement using prospective randomized controlled study.
    
    3. Hypothsis 
    Null hypothesis: There were no significant difference of postoperative pancreatif fistula more than grade B between clip reinforcement and endo stapler only group.
    Alternative Hypothesis: The patients with reinforcement of pancreatic resectiono margin show lower incidence of pacnreatic fistula compared with the patients who undergo endo stapler only.
    
    (α value: 5%, (1-β) 80%): postoperative pancreatic fistular incidence in experiemental group and control group was 44.4% and 24.4%, respectively in previous study. To show positive result for alternative hypothesis with statistical significance, we need 95 patients in each group, Total patients are 190 considering 10% of spontaenous loss. 
    
    4.Method
    We perform randomization in patients who need laparoscopic distal pancreatectomy for pancreatic neoplasm of tail portion.
    - Experiment: reinforcement after laparoscopic distal pancreatectomy 
    - Control: non-reinforcement after laparoscopic distal pancreatectomy
  • 8. Study Design

    Study Design Information - Study Type, Study Purpose, Phase, Intervention Model, Blinding/Masking, Blinded Subject, Allocation, Intervention Type, Intervention Description, Number of Arms, Arm Label, Target Number of Participant, Arm Type, Arm Description
    Study Type Interventional Study
    Study Purpose
    Others
    (This study is aimed to compare postoperative pancreatic fistula between reinforcement and non-reinforcement after laparoscopic distal pancreatectomy in patients)
    Phase Not applicable
    Intervention Model Parallel  
    Blinding/Masking Single
    Blinded Subject Subject
    Allocation RCT
    Intervention Type /Procedure/Surgery  
    Intervention Description
    This study was described for all patients scheduled for laparoscopic distal pancreatectomy  for pancreatic tail lesions after consenting process.
    The randomization will be performed as 1:1 ratio, and both patient groups undergo common spleen preservation or pancreatic tailectomy including splenectomy.
    
    The control group and the experimental group performed laparoscopic surgery using 5-6 trocars. The detailed operation procedure is as follows. After separating omentum and we confirm the lesion of the pancreas, the lower border of the pancreas is dissected, and the superior mesenteric vein and splenic vein are identified. After dissecting the upper margin of the pancreas, the pancreas neck is tunneled, and the pancreas is separated using an automatic suture above or to the left of the superior mesenteric vein according to the location of the tumor. In the case of the control group, sepration using endo stapler only and remnant surgery will be performed, and in the case of the experimental group, the transection line will be reinforced using a 5mm metal clip. Later, in the case of general pancreatic resection, the spleen vessels are excised, and the spleen is also excised. In the case of preservation of splenic vessels, the pancreatic parenchyma is removed while preserving the splenic arteries and veins, and in the case of the warshaw procedure, the splenic vessels are excised and separated by dissecting at the splenic hilum level. In the case of pancreatic cancer, lymph node around common hepatic artery and splenic vessel will be dissected and anterior radical antemodular pancreatosplenectomy are performed as needed. After placing the drain near the pancreatic resection surface, the operation is completed.
    Number of Arms 2
    Arm 1

    Arm Label

    Experiment

    Target Number of Participant

    95

    Arm Type

    Experimental

    Arm Description

    After separating omentum and we confirm the lesion of the pancreas, the lower border of the pancreas is dissected, and the superior mesenteric vein and splenic vein are identified. After dissecting the upper margin of the pancreas, the pancreas neck is tunneled, and the pancreas is separated using an automatic suture above or to the left of the superior mesenteric vein according to the location of the tumor. In the case of the experimental group the transection line will be reinforced using a 5mm metal clip. Later, in the case of general pancreatic resection, the spleen vessels are excised, and the spleen is also excised. In the case of preservation of splenic vessels, the pancreatic parenchyma is removed while preserving the splenic arteries and veins, and in the case of the warshaw procedure, the splenic vessels are excised and separated by dissecting at the splenic hilum level. In the case of pancreatic cancer, lymph node around common hepatic artery and splenic vessel will be dissected and anterior radical antemodular pancreatosplenectomy are performed as needed. After placing the drain near the pancreatic resection surface, the operation is completed.
    Arm 2

    Arm Label

    Control

    Target Number of Participant

    95

    Arm Type

    No intervention

    Arm Description

    After separating omentum and we confirm the lesion of the pancreas, the lower border of the pancreas is dissected, and the superior mesenteric vein and splenic vein are identified. After dissecting the upper margin of the pancreas, the pancreas neck is tunneled, and the pancreas is separated using an automatic suture above or to the left of the superior mesenteric vein according to the location of the tumor. In the case of the control group, sepration using endo stapler only and remnant surgery will be performed. Later, in the case of general pancreatic resection, the spleen vessels are excised, and the spleen is also excised. In the case of preservation of splenic vessels, the pancreatic parenchyma is removed while preserving the splenic arteries and veins, and in the case of the warshaw procedure, the splenic vessels are excised and separated by dissecting at the splenic hilum level. In the case of pancreatic cancer, lymph node around common hepatic artery and splenic vessel will be dissected and anterior radical antemodular pancreatosplenectomy are performed as needed. After placing the drain near the pancreatic resection surface, the operation is completed.
  • 9. Subject Eligibility

    Subject Eligibility Information
    Condition(s)/Problem(s) * (C00-D48)Neoplasms 
       (C25.9)Malignant neoplasm of pancreas, unspecified 

    The patients who need laparoscopic distal pancreatectomy for pancreatic neoplasm of tail portion.
    Rare Disease No
    Inclusion Criteria

    Gender

    Both

    Age

    18Year~79Year

    Description

    - Age more than 18, less than 80
    - Performance status: ECOG 0-2
    - pancreatic benign or malignant neoplasm in preoperative examination
    - No distance metastasis
    - Intact bone marrow function: WBC at least 3,000/mm3, Platelet count at least 100,000/mm3
    - Intact renal function: Creatinine no greater than 1.5 times upper limit of normal
    - Patients who can read and understand the informed consent and can express their intent to agree
    Exclusion Criteria
    - The patients with cctive and uncontrollable infection
    - The patients with severe psychologic/neurologic disorder
    - Alcoholics or drug addiction patient
    - The patients who participated with other clinical studies
    - Patients unable to comply with the researcher`s instruction
    - The patients with moderate or severe underlying disease (liver cirrhosis, chronic renal failure, heart failure, COPD)
    - The patients who need adjuntive organ resection including stomach, colon, and superior mesenteric vein 
    - Unsuitable for research in the opinion of the researcher
    Healthy Volunteers No
  • 10. Outcome Measure(s)

    Outcome Measure(s) Information - Type of Primary Outcome, Primary Outcome, Outcome, Timepoint, Secondary Outcome, Outcome, Timepoint
    Type of Primary Outcome Not applicable
    Primary Outcome(s) 1
    Outcome
    Postoperative pancreatic fistula grade B or more
    Timepoint
    90 days after operation
    Secondary Outcome(s) 1
    Outcome
    Operative time
    Timepoint
    90 days after operation
    Secondary Outcome(s) 2
    Outcome
    Estimated blood loss
    Timepoint
    90 days after operation
    Secondary Outcome(s) 3
    Outcome
    Posoperative complication
    Timepoint
    90 days after operation
    Secondary Outcome(s) 4
    Outcome
    Postoperative laborative finding
    Timepoint
    90 days after operation
    Secondary Outcome(s) 5
    Outcome
    Hospital stay
    Timepoint
    90 days after operation
    Secondary Outcome(s) 6
    Outcome
    comparison pathology finding
    Timepoint
    90 days after operation
  • 11. Study Results and Publication

    Study Results and Publication Information - Result Registered, Final Enrollment Number, Number of Publication, Publications, Results Upload, Date of Posting Results, Protocol URL or File Upload, Brief Summary
    Result Registered No
  • 12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)

    Sharing of Study Data Information - Sharing Statement, Time of Sharing, Way of Sharing
    Sharing Statement No
화면 최상단으로 이동

TOP

BOTTOM

화면 최하단으로 이동